trial

Bizarreness and Anomalous Self Experiences in Schizophrenia

NCTId NCT05966610
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Unknown
Enrollment 12 (estimated)
Sponsored by University Hospital, Toulouse
Primary completion 2024-07-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
12 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2023-07-12
Primary completion
2024-07-01
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
—

Sponsors

University Hospital, ToulouseLead Sponsor

Investigators

1
TUDI L GOZE, MDPrincipal Investigator

Sites

1 total
Toulouse, France

Facts & assertions

4 sourced
Enrollment
12
Phase
NA
Primary Completion Date
2024-07-01
Status
UNKNOWN
relationships
The graph out of here
lead_sponsor
University Hospital, Toulouse
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
TUDI L GOZE, MD
person